Non-Coding RNAs and Endometrial Cancer

Cristina Vallone, Giuliano Rigon, Caterina Gulia, Alberto Baffa, Raffaella Votino, Giulia Morosetti, Simona Zaami, Vito Briganti, Francesco Catania, Marco Gaffi, Roberto Nucciotti, Fabio Massimo Costantini, Roberto Piergentili, Lorenza Putignani, Fabrizio Signore

Research output: Contribution to journalReview articlepeer-review


Non-coding RNAs (ncRNAs) are involved in the regulation of cell metabolism and neoplastic transformation. Recent studies have tried to clarify the significance of these information carriers in the genesis and progression of various cancers and their use as biomarkers for the disease; possible targets for the inhibition of growth and invasion by the neoplastic cells have been suggested. The significance of ncRNAs in lung cancer, bladder cancer, kidney cancer, and melanoma has been amply investigated with important results. Recently, the role of long non-coding RNAs (lncRNAs) has also been included in cancer studies. Studies on the relation between endometrial cancer (EC) and ncRNAs, such as small ncRNAs or micro RNAs (miRNAs), transfer RNAs (tRNAs), ribosomal RNAs (rRNAs), antisense RNAs (asRNAs), small nuclear RNAs (snRNAs), Piwi-interacting RNAs (piRNAs), small nucleolar RNAs (snoRNAs), competing endogenous RNAs (ceRNAs), lncRNAs, and long intergenic ncRNAs (lincRNAs) have been published. The recent literature produced in the last three years was extracted from PubMed by two independent readers, which was then selected for the possible relation between ncRNAs, oncogenesis in general, and EC in particular.

Original languageEnglish
Number of pages25
Issue number4
Publication statusPublished - Mar 29 2018


Dive into the research topics of 'Non-Coding RNAs and Endometrial Cancer'. Together they form a unique fingerprint.

Cite this